UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13G-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13G-1 (b),
(c) AND (d) AND
AMENDMENTS THERETO FILED PURSUANT TO 13G-2
(Amendment No.
)
BIOFORM MEDICAL, INC.
(Name of Issuer)
COMMON STOCK, PAR VALUE $0.01 PER SHARE
(Title of Class of Securities)
09065G 10 7
DECEMBER 31, 2007
(Date of Event Which Requires Filing of This Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
|
|
|
|
o
Rule 13d-1(b)
|
|
|
|
|
|
|
o
Rule 13d-1(c)
|
|
|
|
|
|
|
þ
Rule 13d-1(d)
|
The remainder of this cover page shall be filled out for a reporting person’s initial filing on
this form with respect to the subject class of securities, and for any subsequent amendment
containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for
the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to
the liabilities of that section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).
|
|
|
|
|
|
|
|
|
|
|
|
|
CUSIP No.
|
|
09065G 10 7
|
13 G
|
Page
|
|
2
|
|
of
|
|
10 Pages
|
|
|
|
|
|
|
|
|
1
|
|
NAMES OF REPORTING PERSONS.
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Pinto Technology Ventures, L.P. I.R.S. ID No.: 27-0049242
|
|
|
|
|
|
|
|
|
|
2
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF
A GROUP*
|
|
|
(a)
o
|
|
|
(b)
þ
(1)
|
|
|
|
|
|
3
|
|
SEC USE ONLY
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
|
|
|
Delaware, United States of America
|
|
|
|
|
|
|
|
5
|
|
SOLE VOTING POWER
|
|
|
|
|
|
NUMBER OF
|
|
0 shares
|
|
|
|
|
|
|
SHARES
|
6
|
|
SHARED VOTING POWER
|
|
BENEFICIALLY
|
|
|
|
OWNED BY
|
|
6,338,599 shares of Common Stock (2)
|
|
|
|
|
|
|
EACH
|
7
|
|
SOLE DISPOSITIVE POWER
|
|
REPORTING
|
|
|
|
PERSON
|
|
0 shares
|
|
|
|
|
|
|
WITH
|
8
|
|
SHARED DISPOSITIVE POWER
|
|
|
|
|
|
|
|
6,338,599 shares of Common Stock (2)
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
|
|
|
6,338,599 shares of Common Stock (2)
|
|
|
|
|
|
10
|
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW
(9) EXCLUDES CERTAIN SHARES*
|
|
|
|
|
|
o
|
|
|
|
|
|
11
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
|
|
|
|
|
|
13.71%(3)
|
|
|
|
|
|
12
|
|
TYPE OF REPORTING PERSON*
|
|
|
|
|
|
PN
|
(1) This Schedule 13G
’s filed by Pinto Technology Ventures, L.P. (“Pinto LP”),
Pinto Technology Ventures GP, L.P. (“Pinto GP”), Pinto TV GP Company LLC
(“Pinto LLC”), Matthew S. Crawford (“Crawford”) and Evan S. Melrose
(“Melrose,” together with Pinto LP, Pinto GP, Pinto LLC and Crawford, the “Reporting Persons”). The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.
(2)
Shares held by Pinto LP. Pinto LLC serves as the sole general partner
of Pinto GP, which serves as the sole general partner of Pinto LP.
Pinto LLC and Pinto GP own no securities of the Issuer directly and
share power to vote and dispose of the shares held by Pinto LP.
Crawford and Melrose serve as managers of Pinto LLC and may be deemed to share power to vote and dispose of the shares held by Pinto LP, however, they disclaim beneficial ownership of the shares held by Pinto
LP, except to the extent of their pecuniary interests therein and any shares held in their name.
(3) This percentage is calculated based upon 46,216,890 shares of Common Stock outstanding (as of November 30, 2007) as set forth in the Issuer’s most recent Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on December 19, 2007.
|
|
|
|
|
|
|
|
|
|
|
|
|
CUSIP No.
|
|
09065G 10 7
|
13 G
|
Page
|
|
3
|
|
of
|
|
10 Pages
|
|
|
|
|
|
|
|
|
1
|
|
NAMES OF REPORTING PERSONS.
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Pinto Technology Ventures GP, L.P. I.R.S. ID No.: 27-0049236
|
|
|
|
|
|
|
|
|
|
2
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF
A GROUP*
|
|
|
(a)
o
|
|
|
(b)
þ
(1)
|
|
|
|
|
|
3
|
|
SEC USE ONLY
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
|
|
|
Delaware, United States of America
|
|
|
|
|
|
|
|
5
|
|
SOLE VOTING POWER
|
|
|
|
|
|
NUMBER OF
|
|
0 shares
|
|
|
|
|
|
|
SHARES
|
6
|
|
SHARED VOTING POWER
|
|
BENEFICIALLY
|
|
|
|
OWNED BY
|
|
6,338,599 shares of Common Stock (2)
|
|
|
|
|
|
|
EACH
|
7
|
|
SOLE DISPOSITIVE POWER
|
|
REPORTING
|
|
|
|
PERSON
|
|
0 shares
|
|
|
|
|
|
|
WITH
|
8
|
|
SHARED DISPOSITIVE POWER
|
|
|
|
|
|
|
|
6,338,599 shares of Common Stock (2)
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
|
|
|
6,338,599 shares of Common Stock (2)
|
|
|
|
|
|
10
|
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW
(9) EXCLUDES CERTAIN SHARES*
|
|
|
|
|
|
o
|
|
|
|
|
|
11
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
|
|
|
|
|
|
13.71%(3)
|
|
|
|
|
|
12
|
|
TYPE OF REPORTING PERSON*
|
|
|
|
|
|
PN
|
(1)
This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.
(2)
Shares held by Pinto LP. Pinto LLC serves as the sole general partner
of Pinto GP, which serves as the sole general partner of Pinto LP.
Pinto LLC and Pinto GP own no securities of the Issuer directly and
share power to vote and dispose of the shares held by Pinto LP.
Crawford and Melrose serve as managers of Pinto LLC and may be deemed
to share power to vote and dispose of the shares held by Pinto LP, however, they disclaim beneficial ownership of the shares held by Pinto
LP, except to the extent of their pecuniary interests therein and any shares held in their name.
(3) This percentage is calculated based upon 46,216,890 shares of Common Stock outstanding (as of November 30, 2007) as set forth in the Issuer’s most recent Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on December 19, 2007.
|
|
|
|
|
|
|
|
|
|
|
|
|
CUSIP No.
|
|
09065G 10 7
|
13 G
|
Page
|
|
4
|
|
of
|
|
10 Pages
|
|
|
|
|
|
|
|
|
1
|
|
NAMES OF REPORTING PERSONS.
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Pinto TV GP Company LLC I.R.S. ID No.: 43-2059018
|
|
|
|
|
|
|
|
|
|
2
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
|
|
(a)
o
|
|
|
(b)
þ
(1)
|
|
|
|
|
|
3
|
|
SEC USE ONLY
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
|
|
|
Delaware, United States of America
|
|
|
|
|
|
|
|
5
|
|
SOLE VOTING POWER
|
|
|
|
|
|
NUMBER OF
|
|
0 shares
|
|
|
|
|
|
|
SHARES
|
6
|
|
SHARED VOTING POWER
|
|
BENEFICIALLY
|
|
|
|
OWNED BY
|
|
6,338,599 shares of Common Stock (2)
|
|
|
|
|
|
|
EACH
|
7
|
|
SOLE DISPOSITIVE POWER
|
|
REPORTING
|
|
|
|
PERSON
|
|
0 shares
|
|
|
|
|
|
|
WITH
|
8
|
|
SHARED DISPOSITIVE POWER
|
|
|
|
|
|
|
|
6,338,599 shares of Common Stock (2)
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
|
|
|
6,338,599 shares of Common Stock (2)
|
|
|
|
|
|
10
|
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|
|
|
|
|
|
o
|
|
|
|
|
|
11
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
|
|
|
|
|
|
13.71%(3)
|
|
|
|
|
|
12
|
|
TYPE OF REPORTING PERSON*
|
|
|
|
|
|
OO
|
(1) This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.
(2) Shares
held by Pinto LP. Pinto LLC serves as the sole general partner of
Pinto GP, which serves as the sole general partner of Pinto LP. Pinto
LLC and Pinto GP own no securities of the Issuer directly and share
power to vote and dispose of the shares held by Pinto LP. Crawford
and Melrose serve as managers of Pinto LLC and may be deemed to share power to vote and dispose of the shares held by Pinto LP, however, they disclaim beneficial ownership of the shares held by Pinto
LP, except to the extent of their pecuniary interests therein and any shares held in their name.
(3) This percentage is calculated based upon 46,216,890 shares of Common Stock outstanding (as of November 30, 2007) as set forth in the Issuer’s most recent Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on December 19, 2007.
|
|
|
|
|
|
|
|
|
|
|
|
|
CUSIP No.
|
|
09065G 10 7
|
13 G
|
Page
|
|
5
|
|
of
|
|
10 Pages
|
|
|
|
|
|
|
|
|
1
|
|
NAMES OF REPORTING PERSONS.
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Matthew S. Crawford
|
|
|
|
|
|
|
|
|
|
2
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF
A GROUP*
|
|
|
(a)
o
|
|
|
(b)
þ
(1)
|
|
|
|
|
|
3
|
|
SEC USE ONLY
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
|
|
|
United States of America
|
|
|
|
|
|
|
|
5
|
|
SOLE VOTING POWER
|
|
|
|
|
|
NUMBER OF
|
|
0 shares of Common Stock
|
|
|
|
|
|
|
SHARES
|
6
|
|
SHARED VOTING POWER
|
|
BENEFICIALLY
|
|
|
|
OWNED BY
|
|
6,338,599 shares of Common Stock (2)
|
|
|
|
|
|
|
EACH
|
7
|
|
SOLE DISPOSITIVE POWER
|
|
REPORTING
|
|
|
|
PERSON
|
|
0 shares of Common Stock
|
|
|
|
|
|
|
WITH
|
8
|
|
SHARED DISPOSITIVE POWER
|
|
|
|
|
|
|
|
6,338,599 shares of Common Stock (2)
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
|
|
|
6,338,599 shares of Common Stock (2)
|
|
|
|
|
|
10
|
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW
(9) EXCLUDES CERTAIN SHARES*
|
|
|
|
|
|
o
|
|
|
|
|
|
11
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
|
|
|
|
|
|
13.71%(3)
|
|
|
|
|
|
12
|
|
TYPE OF REPORTING PERSON*
|
|
|
|
|
|
IN
|
(1) This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.
(2)
Shares held by Pinto LP. Pinto LLC serves as the sole general partner
of Pinto GP, which serves as the sole general partner of Pinto LP.
Pinto LLC and Pinto GP own no securities of the Issuer directly and share power to vote and dispose of the shares held by Pinto LP. Crawford and Melrose serve as managers of Pinto LLC and
may be deemed to share power to vote and dispose of the shares held by Pinto LP, however, they disclaim beneficial ownership of the shares held by Pinto
LP, except to the extent of their pecuniary interests therein and any shares held in their name.
(3) This percentage is calculated based upon 46,216,890 shares of Common Stock outstanding (as of November 30, 2007) as set forth in the Issuer’s most recent Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on December 19, 2007.
|
|
|
|
|
|
|
|
|
|
|
|
|
CUSIP No.
|
|
09065G 10 7
|
13 G
|
Page
|
|
6
|
|
of
|
|
10 Pages
|
|
|
|
|
|
|
|
|
1
|
|
NAMES OF REPORTING PERSONS.
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Evan S. Melrose
|
|
|
|
|
|
|
|
|
|
2
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
|
|
(a)
o
|
|
|
(b)
þ
(1)
|
|
|
|
|
|
3
|
|
SEC USE ONLY
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
|
|
|
United States of America
|
|
|
|
|
|
|
|
5
|
|
SOLE VOTING POWER
|
|
|
|
|
|
NUMBER OF
|
|
0 shares of Common Stock
|
|
|
|
|
|
|
SHARES
|
6
|
|
SHARED VOTING POWER
|
|
BENEFICIALLY
|
|
|
|
OWNED BY
|
|
6,338,599 shares of Common Stock (2)
|
|
|
|
|
|
|
EACH
|
7
|
|
SOLE DISPOSITIVE POWER
|
|
REPORTING
|
|
|
|
PERSON
|
|
0 shares of Common Stock
|
|
|
|
|
|
|
WITH
|
8
|
|
SHARED DISPOSITIVE POWER
|
|
|
|
|
|
|
|
6,338,599 shares of Common Stock (2)
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
|
|
|
6,338,599 shares of Common Stock (2)
|
|
|
|
|
|
10
|
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|
|
|
|
|
|
o
|
|
|
|
|
|
11
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
|
|
|
|
|
|
13.71%(3)
|
|
|
|
|
|
12
|
|
TYPE OF REPORTING PERSON*
|
|
|
|
|
|
IN
|
(1) This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.
(2) Shares
held by Pinto LP. Pinto LLC serves as the sole general partner of Pinto GP, which serves as the sole general partner of Pinto LP. Pinto LLC and Pinto GP own no securities of the Issuer directly and share power to vote and dispose of the shares held by Pinto LP. Crawford and Melrose serve as managers of Pinto LLC and
may be deemed to share power to vote and dispose of the shares held by Pinto LP, however, they disclaim beneficial ownership of the shares held by Pinto
LP, except to the extent of their pecuniary interests therein and any shares held in their name.
(3) This percentage is calculated based upon 46,216,890 shares of Common Stock outstanding (as of November 30, 2007) as set forth in the Issuer’s most recent Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on December 19, 2007.
Introductory Note: This Statement on Schedule 13G is filed on behalf of the Reporting Persons, in
respect of shares of Common Stock, par value $0.01 per share (“Common Stock”), of BioForm Medical,
Inc. (the “Issuer”).
Item 1
BioForm Medical, Inc., a Delaware corporation
|
(b)
|
|
Address of Issuer’s Principal Executive Offices:
|
1875
South Grant Street, Suite 110
San Mateo, California 94402
Item 2
|
(a)
|
|
Name of Person(s) Filing:
|
Pinto Technology Ventures, L.P. (“Pinto LP”)
Pinto Technology Ventures GP, L.P. (“Pinto GP”)
Pinto TV GP Company LLC (“Pinto LLC”)
Matthew S. Crawford (“Crawford”)
Evan S. Melrose (“Melrose”)
|
(b)
|
|
Address of Principal Business Office:
|
c/o PTV Sciences
221 West 6
th
Street, Suite 700
Austin, Texas 78701
Citizenship:
|
|
|
|
|
|
|
|
|
|
|
|
|
Entities:
|
|
Pinto LP
|
|
—
|
|
Delaware, United States of America
|
|
|
|
|
|
Pinto GP
|
|
—
|
|
Delaware, United States of America
|
|
|
|
|
|
Pinto LLC
|
|
—
|
|
Delaware, United States of America
|
|
|
|
Individuals:
|
|
Crawford
|
|
—
|
|
United States of America
|
|
|
|
|
|
Melrose
|
|
—
|
|
United States of America
|
|
(d)
|
|
Title of Class of Securities: Common Stock
|
|
|
|
(e)
|
|
CUSIP Number: 09065G 10 7
|
Item 3
Not applicable.
7.
Item 4 Ownership
.
The following information with respect to the ownership of the Common Stock by the Reporting
Persons filing this statement on Schedule 13G is provided as of December 31, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sole
|
|
Shared
|
|
Sole
|
|
Shared
|
|
|
|
|
|
|
|
Shares Held
|
|
Voting
|
|
Voting
|
|
Dispositive
|
|
Dispositive
|
|
Beneficial
|
|
Percentage
|
|
Reporting Persons
|
|
Directly
|
|
Power
|
|
Power
|
|
Power
|
|
Power
|
|
Ownership
|
|
of Class (1)
|
|
Pinto LP
|
|
|
6,338,599
|
|
|
|
0
|
|
|
|
6,338,599
|
|
|
|
0
|
|
|
|
6,338,599
|
|
|
|
6,338,599
|
|
|
|
13.71
|
%
|
|
|
|
Pinto GP (2)
|
|
|
0
|
|
|
|
0
|
|
|
|
6,338,599
|
|
|
|
0
|
|
|
|
6,338,599
|
|
|
|
6,338,599
|
|
|
|
13.71
|
%
|
|
|
|
Pinto LLC (2)
|
|
|
0
|
|
|
|
0
|
|
|
|
6,338,599
|
|
|
|
0
|
|
|
|
6,338,599
|
|
|
|
6,338,599
|
|
|
|
13.71
|
%
|
|
|
|
Crawford (2)
|
|
|
0
|
|
|
|
0
|
|
|
|
6,338,599
|
|
|
|
0
|
|
|
|
6,338,599
|
|
|
|
6,338,599
|
|
|
|
13.71
|
%
|
|
|
|
Melrose (2)
|
|
|
0
|
|
|
|
0
|
|
|
|
6,338,599
|
|
|
|
0
|
|
|
|
6,338,599
|
|
|
|
6,338,599
|
|
|
|
13.71
|
%
|
|
|
|
|
|
(1)
|
|
This percentage is calculated based upon 46,216,890 shares of Common Stock outstanding (as of
November 30, 2007) as set forth in the Issuer’s most recent Quarterly Report on Form 10-Q filed
with the Securities and Exchange Commission on December 19, 2007.
|
|
|
|
(2)
|
|
Pinto LLC and Pinto GP own no securities of the Issuer directly and share power to vote and
dispose of the shares held by Pinto LP. Crawford and Melrose serve as
managers of Pinto LLC and may be deemed to
share power to vote and dispose of the shares held by Pinto LP, however, they disclaim beneficial
ownership of the shares held by Pinto LP, except to the extent of their pecuniary interests therein
and any shares held in their name.
|
Item 5 Ownership of Five Percent or Less of a Class
.
If this statement is being filed to report the fact that as of the date hereof, the reporting
person has ceased to be the beneficial owner of more than five percent of the class of securities,
check the following:
o
Item 6 Ownership of More Than Five Percent on Behalf of Another Person
.
Not applicable.
|
|
|
|
|
Item 7
|
|
Identification and Classification of the Subsidiary which Acquired the Security Being
Reported on by the Parent Holding Company
.
|
Not applicable.
Item 8 Identification and Classification of Members of the Group
.
Not applicable.
Item 9 Notice of Dissolution of Group
.
Not applicable.
Item 10 Certification
.
By signing below I certify that, to the best of my knowledge and belief, the securities referred to
above were not acquired and are not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were not acquired and are not held in
connection with or as a participant in any transaction having that purpose or effect.
8.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information
set forth in this statement is true, complete and correct.
Dated: February 13, 2008
|
|
|
|
|
|
|
PINTO TECHNOLOGY VENTURES, L.P.
|
|
|
|
|
|
|
|
|
|
By:
|
|
Pinto Technology Ventures GP, L.P.
|
|
|
|
Its:
|
|
General Partner
|
|
|
|
By:
|
|
Pinto TV GP Company LLC
|
|
|
|
Its:
|
|
General Partner
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Evan S. Melrose, M.D.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name:
|
|
Evan S. Melrose, M.D.
|
|
|
|
|
|
Manager
|
|
|
|
|
|
|
|
|
|
PINTO TECHNOLOGY VENTURES GP, L.P.
|
|
|
|
|
|
|
|
|
|
By:
|
|
Pinto TV GP Company LLC
|
|
|
|
Its:
|
|
General Partner
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Evan S. Melrose, M.D.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name:
|
|
Evan S. Melrose, M.D.
|
|
|
|
|
|
Manager
|
|
|
|
|
|
|
|
|
|
PINTO TV GP COMPANY LLC
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Evan S. Melrose, M.D.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name:
|
|
Evan S. Melrose, M.D.
|
|
|
|
|
|
Manager
|
|
|
|
/s/ Matthew S. Crawford
|
|
|
|
|
|
Matthew S. Crawford
|
|
|
|
/s/ Evan S. Melrose, M.D.
|
|
|
|
|
|
Evan S. Melrose, M.D.
|
|
|
Exhibit(s)
:
A: Joint Filing Statement
9.
EXHIBIT A
JOINT FILING STATEMENT
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the
undersigned hereby agree that only one statement containing the information required by Schedule
13G need be filed with respect to the ownership by each of the undersigned of the shares of Common
Stock of BioForm Medical, Inc.
Dated: February 13, 2008
|
|
|
|
|
|
|
PINTO TECHNOLOGY VENTURES, L.P.
|
|
|
|
|
|
|
|
|
|
By:
|
|
Pinto Technology Ventures GP, L.P.
|
|
|
|
Its:
|
|
General Partner
|
|
|
|
By:
|
|
Pinto TV GP Company LLC
|
|
|
|
Its:
|
|
General Partner
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Evan S. Melrose, M.D.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name:
|
|
Evan S. Melrose, M.D.
|
|
|
|
|
|
Manager
|
|
|
|
|
|
|
|
|
|
PINTO TECHNOLOGY VENTURES GP, L.P.
|
|
|
|
|
|
|
|
|
|
By:
|
|
Pinto TV GP Company LLC
|
|
|
|
Its:
|
|
General Partner
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Evan S. Melrose, M.D.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name:
|
|
Evan S. Melrose, M.D.
|
|
|
|
|
|
Manager
|
|
|
|
|
|
|
|
|
|
PINTO TV GP COMPANY LLC
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Evan S. Melrose, M.D.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name:
|
|
Evan S. Melrose, M.D.
|
|
|
|
|
|
Manager
|
|
|
|
/s/ Matthew S. Crawford
|
|
|
|
|
|
Matthew S. Crawford
|
|
|
|
/s/ Evan S. Melrose, M.D.
|
|
|
|
|
|
Evan S. Melrose, M.D.
|
|
|
10.
Bioform Medical (MM) (NASDAQ:BFRM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bioform Medical (MM) (NASDAQ:BFRM)
Historical Stock Chart
From Jul 2023 to Jul 2024
